000			01566 a2200373 4500
005			20250513034232.0
264		0	_c19950831
008			199508s 0 0 eng d
022			_a1058-4838
024	7		_a10.1093/clinids/20.5.1217 _2doi
040			_aNLM _beng _cNLM
100	1		_aRubinstein, E
245	0	0	_aCeftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group. _h[electronic resource]
260			_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cMay 1995
300			_a1217-28 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCeftazidime _xtherapeutic use
650	0	4	_aCeftriaxone _xtherapeutic use
650	0	4	_aCross Infection _xdrug therapy
650	0	4	_aDrug Therapy, Combination _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGram-Negative Bacterial Infections _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aTobramycin _xtherapeutic use
700	1		_aLode, H
700	1		_aGrassi, C
773	0		_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 20 _gno. 5 _gp. 1217-28
856	4	0	_uhttps://doi.org/10.1093/clinids/20.5.1217 _zAvailable from publisher's website
999			_c7619438 _d7619438